Moxetumomab pasudotox-tdfk Intravenous and Opium Deodorized
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Opium Deodorized and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: opium
Brand name: Opium Deodorized, Paregoric
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Opium preparation
- Moxetumomab pasudotox-tdfk Intravenous-Opium Tincture
- Moxetumomab pasudotox-tdfk Intravenous-Oprelvekin
- Moxetumomab pasudotox-tdfk Intravenous-Oprelvekin Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Opsumit
- Moxetumomab pasudotox-tdfk Intravenous-Opti-Clear
- Opium Deodorized-Moxifloxacin
- Opium Deodorized-Moxifloxacin (Systemic)
- Opium Deodorized-Moxifloxacin Hydrochloride
- Opium Deodorized-Moxifloxacin Injection
- Opium Deodorized-Moxifloxacin Intravenous
- Opium Deodorized-Moxifloxacin Tablets